Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Genprex To Transfer Diabetes Gene Therapy Program Into New Wholly-Owned Subsidiary Focused On Developing GPX-002 For Type 1 And Type 2 Diabetes​

Author: Benzinga Newsdesk | September 04, 2024 09:30am

Posted In: GNPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist